NLRP5 and hepatocellular carcinoma: The findings revealed that the downregulation of NLRP5 significantly compromised the metastatic capacity of HCCLM3 and HEPG2 cells, while the downregulation of NLRP4 did not exert any discernible influence on the metastatic ability of HCC cell lines.